Cargando…

A Six-Gene Prognostic and Predictive Radiotherapy-Based Signature for Early and Locally Advanced Stages in Non-Small-Cell Lung Cancer

SIMPLE SUMMARY: The search for prognostic and/or predictive gene signatures of the response to radiotherapy treatment can significantly aid clinical decision making. These signatures can condition the fractionation, the total dose to be administered, and/or the combination of systemic treatments and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peinado-Serrano, Javier, Quintanal-Villalonga, Álvaro, Muñoz-Galvan, Sandra, Verdugo-Sivianes, Eva M., Mateos, Juan C., Ortiz-Gordillo, María J., Carnero, Amancio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099638/ https://www.ncbi.nlm.nih.gov/pubmed/35565183 http://dx.doi.org/10.3390/cancers14092054

Ejemplares similares

Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer
por: Verdugo-Sivianes, Eva M., et al.
Publicado: (2017)

Role of the Holoenzyme PP1-SPN in the Dephosphorylation of the RB Family of Tumor Suppressors During Cell Cycle
por: Verdugo-Sivianes, Eva M., et al.
Publicado: (2021)

Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells
por: Verdugo-Sivianes, Eva M, et al.
Publicado: (2021)

c‐MYB‐ and PGC1a‐dependent metabolic switch induced by MYBBP1A loss in renal cancer
por: Felipe‐Abrio, Blanca, et al.
Publicado: (2019)

Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer
por: Felipe-Abrio, Blanca, et al.
Publicado: (2019)

Chronotherapy: Circadian Rhythms and Their Influence in Cancer Therapy
por: Amiama-Roig, Ana, et al.
Publicado: (2022)

Implications of maraviroc and/or rapamycin in a mouse model of fragility
por: Pérez-Martínez, Laura, et al.
Publicado: (2020)

Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

Molecular Radiobiology in Non-Small Cell Lung Cancer: Prognostic and Predictive Response Factors
por: Peinado-Serrano, Javier, et al.
Publicado: (2022)

Histology-dependent prognostic role of pERK and p53 protein levels in early-stage non-small cell lung cancer
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2018)

Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy
por: García-Heredia, José M., et al.
Publicado: (2016)

PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry
por: Marrugal, Ángela, et al.
Publicado: (2019)

NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis
por: Lucena-Cacace, Antonio, et al.
Publicado: (2017)

High casein kinase 1 epsilon levels are correlated with better prognosis in subsets of patients with breast cancer
por: Lopez-Guerra, Jose Luis, et al.
Publicado: (2015)

Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2021)

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2020)

MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy
por: Rivero, Maria, et al.
Publicado: (2018)

A new treatment for sarcoma extracted from combination of miRNA deregulation and gene association rules
por: García-Heredia, José Manuel, et al.
Publicado: (2023)

Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy
por: Marrugal, Ángela, et al.
Publicado: (2023)

MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma
por: Ferrer, Irene, et al.
Publicado: (2018)

The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2018)

Sarcoma stratification by combined pH2AX and MAP17 (PDZK1IP1) levels for a better outcome on doxorubicin plus olaparib treatment
por: Perez, Marco, et al.
Publicado: (2020)

New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools
por: Muñoz-Galván, Sandra, et al.
Publicado: (2019)

Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA
por: Perez, Marco, et al.
Publicado: (2015)

NAD pool as an antitumor target against cancer stem cells in head and neck cancer
por: Navas, Lola E., et al.
Publicado: (2023)

Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1)
por: Perez, Marco, et al.
Publicado: (2016)

Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia
por: Narlik-Grassow, Maja, et al.
Publicado: (2013)

Breast tumor cells promotes the horizontal propagation of EMT, stemness, and metastasis by transferring the MAP17 protein between subsets of neoplastic cells
por: García-Heredia, José Manuel, et al.
Publicado: (2020)

An optimized NGS sample preparation protocol for in vitro CRISPR screens
por: Wohlhieter, Corrin A., et al.
Publicado: (2021)

Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications
por: Quintanal-Villalonga, A., et al.
Publicado: (2016)

Corrigendum to “Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications”
por: Quintanal-Villalonga, A., et al.
Publicado: (2018)

Correction: Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia
por: Narlik-Grassow, Maja, et al.
Publicado: (2013)

MAP17, a ROS-dependent oncogene
por: Carnero, Amancio
Publicado: (2012)

MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer
por: de Miguel-Luken, María-José, et al.
Publicado: (2015)

A six-gene-based signature for breast cancer radiotherapy sensitivity estimation
por: Chen, Xing, et al.
Publicado: (2020)

Should We Expect an Increase in the Number of Cancer Cases in People with Long COVID?
por: Amiama-Roig, Ana, et al.
Publicado: (2023)

Identification of Predictive Biomarkers of Response to HSP90 Inhibitors in Lung Adenocarcinoma
por: Marrugal, Ángela, et al.
Publicado: (2021)

CDH18 is a fetal epicardial biomarker regulating differentiation towards vascular smooth muscle cells
por: Junghof, Julia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6n30hs24nu22gs4v7mlif1oqjh